BrIDGs scientists bring decades of experience in industry and academic drug development to each project. Collaborators tap into staff expertise in process chemistry, formulations development, pharmacokinetics and toxicology. These scientific insights are combined with a thorough understanding of regulatory guidelines, which enables the program to provide assistance with establishing and implementing successful product development plans for IND applications.
Completed and active projects include small molecules, peptides, gene therapies and recombinant proteins delivered by oral, topical and injectable routes of administration.